Dermatology MSL – KOL & Clinical Insights

Galderma Laboratories, LP; Boston (MA); On-site; USD 140,000 - 170,000; Full time

Benefits offered by this job

Health insurance

401(k) plan with employer match

Hybrid work schedules

Paid time off

Job summary

Galderma seeks a Medical Science Liaison to support the Nemolizumab program in the US, building relationships with physicians, NP/PAs, and other health care providers. You will deliver scientific information, educate stakeholders on disease states, and ensure compliant communications.

The role emphasizes cross-functional collaboration, data generation support, and travel up to 70–80%. Doctorate-level degree or equivalent is preferred with dermatology/immunology background advantageous.

Qualifications

• Requires Doctorate (PharmD/MD/PhD) with 3+ years in Medical Affairs/MSL.
• Dermatology or Immunology background preferred; strong scientific acumen.
• Excellent communication and presentation skills, ability to interact with HCPs and researchers.

Responsibilities

• Identify key opinion leaders and develop a network within assigned geographies.
• Deliver scientific information on Nemolizumab and related programs to HCPs and institutions.
• Support advisory boards, posthoc analyses, and IIT proposals in a compliant manner.

Skills

KOL engagement

Scientific communication

Cross-functional collaboration

Regulatory compliance

Travel readiness

Regulatory knowledge (FDA/HIPAA)

Education

Doctorate degree (PharmD/MD/PhD)

Tools

CRM software

Medical education platforms

Job description

Galderma seeks a Medical Science Liaison to support the Nemolizumab program in the US, building relationships with physicians, NP/PAs, and other health care providers. You will deliver scientific information, educate stakeholders on disease states, and ensure compliant communications.

The role emphasizes cross-functional collaboration, data generation support, and travel up to 70–80%. Doctorate-level degree or equivalent is preferred with dermatology/immunology background advantageous.